J Korean Soc Clin Toxicol.  2012 Dec;10(2):111-117.

16 Cases of Anti-obesity Drug Intoxication Experienced in 4 Emergency Departments

Affiliations
  • 1Department of Emergency Medicine, College of Medicine, The Catholic University of Korea, St. Vincent's Hospital, Suwon, Korea. dockdo2008@gmail.com

Abstract

PURPOSE
In Korea, few studies have examined the acute toxicity of anti-obesity drugs. The purpose of this study is to analyze the general characteristics and clinical aspect of acute anti-obesity drug intoxication.
METHODS
We retrospectively investigated patients admitted to the emergency department after anti-obesity drug intoxication between March, 2004 and February, 2012. The medical records of these patients were reviewed for demographic data, toxicologic history, time elapsed to presentation, clinical symptoms and signs, treatment, and outcome.
RESULTS
There were a total of 18 anti-obesity intoxication cases during the study period; of 16 which were included in our study. The purchasing route of the anti-obesity drug was mainly through a doctor's prescription (68.8%), however, some were obtained through the internet and the pharmacies. The mean time to The most commonly ingested anti-obesity drug was sibutramine (31.3%) and many of the cases (62.5%) were multi-drug ingestions. The most common clinical manifestations were gastrointestinal symptoms (94%), but, CNS symptoms (75%) and cardiovascular symptoms (75%) were almost equally present. 13 patients (81%) were discharged after clearance of toxic symptoms and signs with a mean observational period of 7.0 hours. 3 patients were admitted for observation and treatment; of which 1 patient died due to fatal complications.
CONCLUSION
Most anti-obesity intoxications show mild toxicity and a nonfatal clinical course. However, the recent trend toward prescribing psychostimulant anti-obesity medication, which can be fatal after an acute overdose, calls physicians' attention to treating of anti-obesity intoxications.

Keyword

Obesity; Anti-obesity drugs; Poisoning

MeSH Terms

Anti-Obesity Agents
Cyclobutanes
Emergencies
Humans
Internet
Korea
Medical Records
Obesity
Pharmacies
Prescriptions
Retrospective Studies
Anti-Obesity Agents
Cyclobutanes
Full Text Links
  • JKSCT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr